Tianjin Chase Sun Pharmaceutical

Tianjin Chase Sun Pharmaceutical is one of the...

• CSI 500.

Tianjin Chase Sun Pharmaceutical is a company listed under the stock ticker 300026 (CN).

View the org chart displaying its 12 main executives

Most searched biographies at Tianjin Chase Sun Pharmaceutical

• Dan Zheng, General Manager and Vice Chairman of the Board
• Xufeng Pu, Director
• Li Li, Independent Director

Create an alert
to follow the executive moves at Tianjin Chase Sun Pharmaceutical.

Tianjin Chase Sun Pharmaceutical has 1,994 competitors including Pfizer (United States (USA)), Johnson & Johnson (United States (USA)) and Roche (Switzerland).

Popular M&A news in Pharmaceuticals

• Catalent Pharma Solutions has acquired Metrics Contract Services (posted on August 12 2022).
• CSL has acquired Vifor Pharma (posted on August 4 2022).
• PharmEasy has just announced a $200 Million fundraising. (posted on July 19 2022).

Popular contacts in Pharmaceuticals

• Danilo Cicmil - Supervisory Board Member at Galenika
• Joaquin Duato - Chief Executive Officer and Director at Johnson & Johnson
• Robert Wessman - Chairman and Chief Executive Officer at Alvogen

Learn more about the Pharmaceuticals industry >

Press releases by Tianjin Chase Sun Pharmaceutical

Social media about Tianjin Chase Sun Pharmaceutical

• Tianjin Chase Sun Pharmaceutical on Wikipedia, Google News & Yahoo Finance
• Tianjin Chase Sun Pharmaceutical on LinkedIn, Twitter & YouTube

Contact by email its executives including Shu Li

Call Tianjin Chase Sun Pharmaceutical at +86 225...

View the org chart

Register to receive your alert

Report an error